{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "North Wales",
      "address_1": "1090 Horsham Rd",
      "reason_for_recall": "Failed dissolution specifications",
      "address_2": "",
      "product_quantity": "181,456 bottles",
      "code_info": "Lot #: a) 49O005, 49O006, 49O007, 49O010, Exp 02/2019; b) 49O005, 49O009, 49O010, Exp 02/2019",
      "center_classification_date": "20190116",
      "distribution_pattern": "U.S.A. nationwide",
      "state": "PA",
      "product_description": "Olmesartan Medoxomil and Hydrochlorothiazide Tablets, 40 mg/25 mg, packaged in a) 30-count bottle (NDC 0093-7617-56), b) 90-count bottle (NDC 0093-7617-98), Rx only, Manufactured In Israel By: Teva Pharmaceutical, IND. LTD., Jerusalem, 9777402, Israel, Manufactured For: Teva Pharmaceutical USA, INC., North Wales, PA 19454",
      "report_date": "20190123",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Teva Pharmaceuticals USA",
      "recall_number": "D-0381-2019",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "81840",
      "termination_date": "20200831",
      "more_code_info": "",
      "recall_initiation_date": "20181219",
      "postal_code": "19454-1505",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}